Latest Breaking News On - Portage biotech inc - Page 3 : comparemela.com

Portage Biotech Announces Plans to Expand its Evaluation of Strategic Alternatives

Portage Biotech Announces Plans to Expand its Evaluation of Strategic Alternatives
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Company annual report on formExchange commissionPortage biotech incBiotech announces plansPortage biotechAnnual report

Baystreet ca - Portage Down on Announcing Alternatives

Portage Biotech Inc. (NASDAQ: PRTG) shares stumbled Friday, as the Westport, Conn.-based company a clinical-stage immuno-oncology concern advancing novel multi-targeted therapies for use as monotherapy and in combination, today reported that it is expanding .

Portage biotech incPortage biotech

Portage Biotech Completes Monetization of Intensity

Company generated approximately $2.8M of non-dilutive funding to extend cash runway.

United statesIan waltersPortage biotech incSociety for immunotherapy of cancerCompany annual report on formAmerican society of clinical oncologyIntensity therapeuticsClinical oncologyAnnual meetingChief executive officerPortage biotechAnnual report

Portage Biotech Reports Results for Fiscal Quarter Ended December 31, 2023, and Business Update

Portage Biotech Reports Results for Fiscal Quarter Ended December 31, 2023, and Business Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesIan waltersCompany board of directorsTrial safety committeeOwners of the companyCompany annual report on formAmerican society of clinical oncologySociety for immunotherapy of cancerPortage biotech incClinical oncologyAnnual meetingChief executive officerQuarter ended decemberRegistered direct offeringIntensity therapeutics

Portage Biotech Reports Results for Fiscal Quarter Ended

Portage Biotech Reports Results for Fiscal Quarter Ended December 31, 2023, and Business Update Company focused on adenosine platform clinical development.

United kingdomUnited statesIan waltersPortage biotech incCompany board of directorsCompany annual report on formTrial safety committeeOwners of the companySociety for immunotherapy of cancerAmerican society of clinical oncologyClinical oncologyAnnual meetingChief executive officerQuarter ended decemberRegistered direct offeringIntensity therapeutics